Indian Journal of Critical Care Medicine

Register      Login



Volume / Issue

Online First

Related articles

VOLUME 25 , ISSUE 8 ( August, 2021 ) > List of Articles


We Know the Prognosis but can We Change It?

Citation Information : We Know the Prognosis but can We Change It?. Indian J Crit Care Med 2021; 25 (8):835-836.

DOI: 10.5005/jp-journals-10071-23955

License: CC BY-NC 4.0

Published Online: 12-08-2021

Copyright Statement:  Copyright © 2021; The Author(s).


  1. Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. JAMA 2020;324(8): 782–793. DOI: 10.1001/jama.2020.12839.
  2. Gallo Marin B, Aghagoli G, Lavine K, Yang L, Siff EJ, Chiang SS, et al. Predictors of COVID-19 severity: a literature review. Rev Med Virol 2021;31(1):1–10. DOI: 10.1002/rmv.2146.
  3. Garibaldi BT, Fiksel J, Muschelli J, Robinson ML, Rouhizadeh M, Perin J, et al. Patient trajectories among persons hospitalized for COVID-19: a cohort study. Ann Intern Med 2021;174(1):33–41. DOI: 10.7326/M20-3905.
  4. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA - J Am Med Assoc 2020;323(13):1239–1242. DOI: 10.1001/jama.2020.2648.
  5. Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med 2020;1–10. DOI: 10.1001/jamainternmed.2020.0994.
  6. Côté A, Ternacle J, Pibarot P. Early prediction of the risk of severe coronavirus disease 2019: a key step in therapeutic decision making. EBioMedicine 2020;59:0–2. DOI: 10.1016/j.ebiom.2020.102948.
  7. Singh Y, Singh A, Rudravaram S, Soni KD, Aggarwal R Patel N, et al. Neutrophil-to-lymphocyte Ratio and Platelet-to-lymphocyte Ratio as Markers for predicting the Severity in COVID-19 Patients: A Prospective Observational Study. Indian J Crit Care Med 2021;25(8):847–853.
  8. Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020;382(18): 1708–1720. DOI: 10.1056/NEJMoa2002032.
  9. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA - J Am Med Assoc 2020;323(11):1061–1069. DOI: 10.1001/jama.2020.1585.
  10. Słomka A, Kowalewski M, Żekanowska E. Coronavirus disease 2019 (COVID–19): a short review on hematological manifestations. Pathogens 2020;9(6):1–19. DOI: 10.3390/pathogens9060493.
  11. Wang X, Li X, Shang Y, Wang J, Zhang X, Su D, et al. Ratios of neutrophil-to-lymphocyte and platelet-to-lymphocyte predict all-cause mortality in inpatients with coronavirus disease 2019 (COVID-19): a retrospective cohort study in a single medical center. Epidemiol Infect 2020;148:e211. DOI: 10.1017/S0950268820002071.
  12. Lagunas-Rangel FA. Neutrophil-to-lymphocyte ratio and lymphocyte-to-C-reactive protein ratio in patients with severe coronavirus disease 2019 (COVID-19): a meta-analysis. J Med Virol 2020;92(10):1733–1734. DOI: 10.1002/jmv.25819.
  13. Xiao LS, Zhang WF, Gong MC, Zhang YP, Chen LY, Zhu HB, et al. Development and validation of the HNC-LL score for predicting the severity of coronavirus disease 2019. EBioMedicine 2020;57. DOI: 10.1016/j.ebiom.2020.102880.
  14. Peter H, Shen LW. Dexamethasone in hospitalized patients with Covid-19. N Engl J Med 2021;384(8):693–704. DOI: 10.1056/NEJMoa2021436.
  15. Weinreich DM, Sivapalasingam S, Norton T, Ali S, Gao H, Bhore R, et al. REGN-COV2, a neutralizing antibody cocktail, in outpatients with Covid-19. N Engl J Med 2021;384(3):238–251. DOI: 10.1056/NEJMoa2035002.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.